Edition:
India

Healthcare

NOIN.BO
CLAI.BO
BORO.BO

UPDATE 2-German drugmaker Stada opens books to rival bidders

* Advent won't withdraw offer after deadline-sources (Adds sources on Advent bid)

BRIEF-Palestine's Beit Jala Pharmaceutical Manufacturing board proposes 15 pct cash dividend

* Board proposes cash dividend of 15 percent of share nominal value for year 2016 Source: (http://bit.ly/2kYzcmZ) Further company coverage:

12:26pm IST

Buffett mulls change to canny Bank of America stake if dividend rises

Feb 25 Warren Buffett said on Saturday he plans to stick with the shrewd bet that his Berkshire Hathaway Inc made on Bank of America Corp, but might eventually swap the preferred stock that Berkshire owns into common stock.

Regulatory News, IPOs 25 Feb 2017

Stada says starts due diligence in M&A process

FRANKFURT, Feb 25 German generic drugs maker Stada Arzneimittel said on Saturday it had started a structured bidding process after receiving takeover bids from three buyout groups.

UPDATE 1-Pfizer subpoenaed in U.S. over patient assistance plans

Feb 24 Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.

25 Feb 2017

More From Around the Web

BSE OIL & GAS -0.26%
BSE BANKEX +0.07%
BSE METALS +0.39%
BSE REALTY +0.78%
BSE AUTO -0.06%
BSE POWER -0.68%
BSE-CG +0.29%

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Photo

India lobbies Trump administration to avert visa threat

NEW DELHI India has stepped up its lobbying effort against moves in the U. S. Congress to impose curbs on visas for skilled workers that threaten the South Asian nation's tech sector, which employs more than 3.5 million people.